Alnylam Pharmaceuticals Inc
(HAM:DUL)
€
279.1
+6.6 (+2.42%)
Market Cap: 37.70 Bil
Enterprise Value: 36.18 Bil
PE Ratio: 85.53
PB Ratio: 38.84
GF Score: 74/100 Sorry the transcript is not found. Please try another one.